BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38547864)

  • 1. Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity.
    Tong L; Chen Z; Li Y; Wang X; Yang C; Li Y; Zhu Y; Lu Y; Liu Q; Xu N; Shao S; Wu L; Zhang P; Wu G; Wu X; Chen X; Fang J; Jia R; Xu T; Li B; Zheng L; Liu J; Tong X
    Cell Metab; 2024 May; 36(5):1013-1029.e5. PubMed ID: 38547864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transketolase Deficiency Protects the Liver from DNA Damage by Increasing Levels of Ribose 5-Phosphate and Nucleotides.
    Li M; Lu Y; Li Y; Tong L; Gu XC; Meng J; Zhu Y; Wu L; Feng M; Tian N; Zhang P; Xu T; Lin SH; Tong X
    Cancer Res; 2019 Jul; 79(14):3689-3701. PubMed ID: 31101762
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
    Jia D; Liu C; Zhu Z; Cao Y; Wen W; Hong Z; Liu Y; Liu E; Chen L; Chen C; Gu Y; Jiao B; Chai Y; Wang HY; Fu J; Chen X
    Clin Transl Med; 2022 Nov; 12(11):e1095. PubMed ID: 36314067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
    Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
    J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation.
    Li M; Zhao X; Yong H; Xu J; Qu P; Qiao S; Hou P; Li Z; Chu S; Zheng J; Bai J
    Cell Death Dis; 2022 Feb; 13(2):99. PubMed ID: 35110545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines.
    Li M; Zhang X; Lu Y; Meng S; Quan H; Hou P; Tong P; Chai D; Gao X; Zheng J; Tong X; Bai J
    Cell Death Dis; 2020 Jan; 11(1):31. PubMed ID: 31949131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARIS reprograms glucose metabolism by HIF-1α induction in dopaminergic neurodegeneration.
    Kang H; Jo A; Kim H; Khang R; Lee JY; Kim H; Park CH; Choi JY; Lee Y; Shin JH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2498-2504. PubMed ID: 29287724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of transketolase as a target of PARIS in substantia nigra.
    Kim H; Kang H; Lee Y; Park CH; Jo A; Khang R; Shin JH
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1050-1056. PubMed ID: 28939041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models.
    Zhao QY; Ge LH; Zhang K; Chen HF; Zhan XX; Yang Y; Dang QL; Zheng Y; Zhou HB; Lyu JX; Fang HZ
    Zool Res; 2020 Sep; 41(5):539-551. PubMed ID: 32786176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transketolase drives the development of aortic dissection by impairing mitochondrial bioenergetics.
    Wang C; Zhang L; Zhang Q; Zheng H; Yang X; Cai W; Zou Q; Lin J; Zhang L; Zhong L; Li X; Liao Y; Liu Q; Chen L; Li Y
    Acta Physiol (Oxf); 2024 Apr; 240(4):e14113. PubMed ID: 38380737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway.
    Tseng CW; Kuo WH; Chan SH; Chan HL; Chang KJ; Wang LH
    Cancer Res; 2018 Jun; 78(11):2799-2812. PubMed ID: 29599405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transketolase Deficiency in Adipose Tissues Protects Mice From Diet-Induced Obesity by Promoting Lipolysis.
    Tian N; Liu Q; Li Y; Tong L; Lu Y; Zhu Y; Zhang P; Chen H; Hu L; Meng J; Feng M; Li M; Zheng L; Li B; Xu T; Wu L; Tong X
    Diabetes; 2020 Jul; 69(7):1355-1367. PubMed ID: 32295803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TKT maintains intestinal ATP production and inhibits apoptosis-induced colitis.
    Tian N; Hu L; Lu Y; Tong L; Feng M; Liu Q; Li Y; Zhu Y; Wu L; Ji Y; Zhang P; Xu T; Tong X
    Cell Death Dis; 2021 Sep; 12(10):853. PubMed ID: 34535624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transketolase haploinsufficiency reduces adipose tissue and female fertility in mice.
    Xu ZP; Wawrousek EF; Piatigorsky J
    Mol Cell Biol; 2002 Sep; 22(17):6142-7. PubMed ID: 12167708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of transketolase promotes the anti-diabetic role of brown adipose tissues.
    Ji Y; Liu W; Zhu Y; Li Y; Lu Y; Liu Q; Tong L; Hu L; Xu N; Chen Z; Tian N; Wu L; Zhu L; Tang S; Zhang P; Tong X
    J Endocrinol; 2023 Mar; 256(3):. PubMed ID: 36449405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transketolase in human Müller cells is critical to resist light stress through the pentose phosphate and NRF2 pathways.
    Chen Y; Zhang T; Zeng S; Xu R; Jin K; Coorey NJ; Wang Y; Wang K; Lee SR; Yam M; Zhu M; Chang A; Fan X; Zhang M; Du J; Gillies MC; Zhu L
    Redox Biol; 2022 Aug; 54():102379. PubMed ID: 35779441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Tkt promotes ischemic heart failure via the cleaved Parp1/Aif axis.
    Wang Z; Qiu Z; Hua S; Yang W; Chen Y; Huang F; Fan Y; Tong L; Xu T; Tong X; Yang K; Jin W
    Basic Res Cardiol; 2022 Apr; 117(1):18. PubMed ID: 35380314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney Dysfunction.
    Chalásová K; Pácal L; Pleskačová A; Knopfová L; Řehořová J; Tomandlová M; Tomandl J; Kaňková K
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):255-262. PubMed ID: 28950391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.
    Schneider S; Lüdtke S; Schröder-Tittmann K; Wechsler C; Meyer D; Tittmann K
    PLoS One; 2012; 7(10):e48321. PubMed ID: 23118983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.
    Gignac T; Trépanier G; Pradeau M; Morissette A; Agrinier AL; Larose É; Marois J; Pilon G; Gagnon C; Vohl MC; Marette A; Carreau AM
    Am J Physiol Endocrinol Metab; 2024 May; 326(5):E616-E625. PubMed ID: 38477665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.